5/3, 11:48 PM (Source: TeleTrader)
more TeleTrader news

FDA to lower age cutoff for Pfizer jab to 12 - report

The Food and Drug Administration (FDA) is set to authorize the Pfizer/BioNTech coronavirus vaccine for use in individuals aged 12 to 15 next week, The New York Times reported citing federal officials familiar with the plan.

The decision would come after the company said results from its trial for the age group showed the inoculation to be 100% effective as no adolescents who received the shot developed symptomatic infections.

The jab is currently available in the US to individuals 16 and older.

Breaking the News / NL